Literature DB >> 19781608

Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation.

Pushp R Nepal1, Hyo-Kyung Han, Hoo-Kyun Choi.   

Abstract

This study aimed to develop a stable solid dispersion of Coenzyme Q(10) (CoQ(10)) with high aqueous solubility and dissolution rate. Among various carriers screened, poloxamer 407 was most effective to form a superior solid dispersion of CoQ(10) having significantly enhanced solubility. Particularly, solid dispersion of CoQ(10) with poloxamer 407 in the weight ratio of 1:5 prepared by melting method enhanced the solubility of CoQ(10) to the greatest extent. However, it exhibited poor stability and hence Aerosil 200 (colloidal silicon dioxide) was incorporated into the solid dispersion as an adsorbent to inhibit the recrystallization process. The solid dispersion of CoQ(10), poloxamer 407 and Aerosil 200 in the weight ratio of 1:5:6 exhibited improved stability with no significant change in solubility during the 1-month stability test. Moreover, the solid dispersion formulation containing Aerosil 200 significantly enhanced the extent of drug release (approx. 75% release) as well as the dissolution rate of CoQ(10). In conclusion, the present study has developed the stable solid dispersion formulation of CoQ(10) with poloxamer 407 and Aerosil 200 for the enhanced solubility and dissolution of CoQ(10), which could also offer some additional advantages including ease of preparation, good flowability and cost-effectiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781608     DOI: 10.1016/j.ijpharm.2009.09.031

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

1.  Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability.

Authors:  Xiuqiong He; Lixia Pei; Henry H Y Tong; Ying Zheng
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.

Authors:  Mohammad Reza Siahi-Shadbad; Saeed Ghanbarzadeh; Mohammad Barzegar-Jalali; Hadi Valizadeh; Alireza Taherpoor; Ghobad Mohammadi; Azim Barzegar-Jalali; Khosro Adibkia
Journal:  Adv Pharm Bull       Date:  2014-08-10

3.  Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.

Authors:  Jaleh Varshosaz; Ladan Dayani; Sana Pirmardvand Chegini; Mohsen Minaiyan
Journal:  IET Nanobiotechnol       Date:  2019-06       Impact factor: 1.847

4.  Amalgamation of solid dispersion and melt adsorption techniques for augmentation of oral bioavailability of novel anticoagulant rivaroxaban.

Authors:  Pranav J Shah; Milan P Patel; Jigar Shah; Anroop B Nair; Sabna Kotta; Bhavin Vyas
Journal:  Drug Deliv Transl Res       Date:  2022-04-25       Impact factor: 4.617

5.  Enhancing solubility and bioavailability of coenzyme Q10: formulation of solid dispersions using Soluplus® as a carrier.

Authors:  Shrawani Lamichhane; Jo-Eun Seo; Taekwang Keum; Gyubin Noh; Santosh Bashyal; Seong-Wan Cho; Eun-Hee Lee; Sangkil Lee
Journal:  Arch Pharm Res       Date:  2022-02-07       Impact factor: 4.946

6.  Nano and Microparticulate Chitosan Based System for Formulation of Carvedilol Rapid Melt Tablet.

Authors:  Ravindra Patil; Vishal Pande; Raju Sonawane
Journal:  Adv Pharm Bull       Date:  2015-06-01

7.  Novel patchouli alcohol ternary solid dispersion pellets prepared by poloxamers.

Authors:  Jin-Bin Liao; Yong-Zhuo Liang; Yun-Long Chen; Jian-Hui Xie; Wei-Hai Liu; Jian Nan Chen; Xiao-Ping Lai; Zi-Ren Su
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

8.  Characterization and Bioavailability of Wogonin by Different Administration Routes in Beagles.

Authors:  Na Zhu; Jian-Chun Li; Jin-Xiu Zhu; Xiu Wang; Jin Zhang
Journal:  Med Sci Monit       Date:  2016-10-16

9.  Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir.

Authors:  Saleha Rehman; Bushra Nabi; Mohammad Fazil; Saba Khan; Naimat Kalim Bari; Romi Singh; Shavej Ahmad; Varinder Kumar; Sanjula Baboota; Javed Ali
Journal:  Biomed Res Int       Date:  2017-10-31       Impact factor: 3.411

10.  Novel lipid-free nanoformulation for improving oral bioavailability of coenzyme Q10.

Authors:  Huafeng Zhou; Guoqing Liu; Jing Zhang; Ning Sun; Mingxing Duan; Zemin Yan; Qiang Xia
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.